PUMA BIOTECHNOLOGY, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2014 | $-77.2M | $-78.3M | $1.1M | $39.2M |
| FY2015 | $-154.5M | $-155.5M | $1.0M | $94.9M |
| FY2016 | $-141.7M | $-146.0M | $4.3M | $117.3M |
| FY2017 | $-172.5M | $-172.9M | $431.0K | $108.7M |
| FY2018 | $-24.1M | $-24.5M | $439.0K | $86.9M |
| FY2019 | $22.4M | $22.1M | $306.0K | $57.3M |
| FY2020 | $773.0K | $727.0K | $46.0K | $36.6M |
| FY2021 | $20.7M | $20.7M | $0 | $32.6M |
| FY2022 | $-15.8M | $-15.8M | $0 | $11.8M |
| FY2023 | $27.0M | $26.9M | $140.0K | $10.2M |